Company intelligence / Profile preview

RevonBioFZ

Dubai, Dubai, United Arab Emirates

Ownership: Private
Development stage: Other

Overview

RevonBio is a biotechnology company based in the Dubai Science Park, United Arab Emirates, focusing on the development and commercialization of innovative therapies. The company operates as a Free Zone Limited Liability Company (FZ-LLC) and aims to bridge the gap between global pharmaceutical innovation and regional healthcare needs in the Middle East and North Africa. RevonBio's primary focus areas include oncology, rare diseases, and infectious diseases, leveraging a network of global partnerships to advance its pipeline. The company is positioned as a regional hub for life sciences research and development, emphasizing the translation of scientific discoveries into clinical applications.

Therapeutic areas: Infectious DiseasesOncologyRare Diseases
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on RevonBioFZ.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RevonBioFZ.

Explore the full profile